INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-0.79 Cr | ₹4.28 Cr | ₹-6.67 Cr | ₹-5.40 Cr | ₹-1.75 Cr |
What is the latest Cash Flow from Investing Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-0.79 Cr |
| Mar2024 | ₹4.28 Cr |
| Mar2023 | ₹-6.67 Cr |
| Mar2022 | ₹-5.40 Cr |
| Mar2021 | ₹-1.75 Cr |
How is Cash Flow from Investing Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.79 Cr | Negative | |
| Mar2024 | ₹4.28 Cr | Positive | |
| Mar2023 | ₹-6.67 Cr | Negative | |
| Mar2022 | ₹-5.40 Cr | Negative | |
| Mar2021 | ₹-1.75 Cr | - | |
Compare Cash Flow from Investing Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹249.5 Cr | -3.8% | -5.5% | -56.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,011.4 Cr | 0.4% | -2.1% | -19.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,999.1 Cr | 0.1% | -0.2% | 2.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,181.6 Cr | 15% | 15.9% | -23.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,023.8 Cr | -6.7% | -19.1% | -41.5% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹480.8 Cr | -1.3% | 3.6% | 20.5% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -3.8% |
-5.5% |
-56.6% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses